Drug Approval | December 12, 2025
Apitoria Pharma receives 3 observations from USFDA for Unit-V
The company will respond to the US FDA within the stipulated timelines
The company will respond to the US FDA within the stipulated timelines
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
Expands bioprocessing footprint across Asia
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Siponimod Tablets is indicated for the treatment of relapsing forms of multiple sclerosis
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
Subscribe To Our Newsletter & Stay Updated
